In review: the life sciences regulatory regime in Italy

This article reviews the essential regulatory considerations surrounding medicines and medical devices in Italy, including clinical trials and marketing authorisations.

Related Keywords

Italy ,Helsinki ,Eteläuomen Läi ,Finland ,Italian , ,National Pharmacovigilance Network ,European Patent Office ,National Institute Of Health ,Ministry Of Economic Development ,National Coordination Centre Of Local Ethics ,Ministry Of Health ,Eu Commission Communication ,Trademark Office ,Italian Ministry Of Health ,Technical Scientific Commission ,Italian National Healthcare Service ,Ministry Of Health Drugs Central Office ,Ministry Of Health Decree ,European Commission ,Community Regulatory Framework ,European Medicines Agency ,Classification Medical Devices Expert Group ,Legislative Decree ,Medicines Code ,European Regulations ,Medical Devices ,Active Implantable Medical Devices ,Medical Device ,Italian Ministry ,National Institute ,Directorates General ,National Coordination Centre ,Local Ethics Committees ,Scientific Institutions ,European Regulation ,Health Circular ,Ministerial Decree ,Member State ,Member States ,Common Technical Document ,Italian Medicines Code ,Reference Member State ,Concerned Member State Medical ,Italian Patent ,European Patent ,Vitaly Medical ,Drugs Central Office ,Economic Development ,Law ,Lawyers ,Legal ,Aw Firms ,Aw Updates ,Egal Updates ,Egal Developments ,Aw Developments ,Egal Newsletters ,Egal Current Awareness ,Deals ,Egal Advisers ,Egal Advisors ,Egal Directory ,Ealthcare Amp Life Sciences ,